| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 251.17 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Human Biomonitoring for Europe (HBM4EU) has established a strategy for deriving prioritized substance groups that HBM4EU will work on in 2019 and 2020. This stepwise strategy included input from national and EU policymakers and from stakeholders. The substances were nominated and prioritized according to a transparent procedure that is described in Deliverable 4.3 on the Prioritisation strategy and criteria, produced by the French Agency for Food, Environmental and Occupational Health & Safety (ANSES). The detailed description of how this prioritization strategy was implemented in practice, the inputs received and the methodology applied for selecting substances to include in the second list of prioritized substances is the subject of the Deliverable D4.4 (lead European Environment Agency, EEA).
Description
Keywords
Environmental health Mycotoxins Human biomonitoring Hazardous properties Exposure characteristics Societal concern
Citation
Alvito P, Silva MJ, Viegas S, editors. Prioritized substance group – Mycotoxins: scoping document (2nd round of prioritization). Brussels: HBM4EU; 2019.